Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06860061

Changes of Higher-Order Aberrations After Different Types of LASIK in Myopia

Changes of Corneal and Total Ocular Higher-Order Aberrations After Conventional LASIK, Femto-LASIK and PRK in Low and Moderate Myopia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Weeks – 45 Weeks
Healthy volunteers
Not accepted

Summary

This prospective comparative interventional study will enroll patients with low and moderate myopia who seek laser vision correction at Sohag Center for LASIK and Corneal Surgeries, Sohag, Egypt. Eyes included will be divided into 3 groups according to the type of refractive surgery used (conventional LASIK, Femto-LASIK and PRK) and each group will be subdivided into 2 groups according to the degree of myopia (low and moderate).

Conditions

Interventions

TypeNameDescription
PROCEDURELaser refractive surgeryThis prospective comparative interventional study will enroll patients with low and moderate myopia who seek laser vision correction at Sohag Center for LASIK and Corneal Surgeries, Sohag, Egypt. Eyes included will be divided into 3 groups according to the type of refractive surgery used (conventional LASIK, Femto-LASIK and PRK) and each group will be subdivided into 2 groups according to the degree of myopia (low and moderate). All patients will be subjected to routine comprehensive preoperative examinations including manifest uncorrected distant visual acuity (UCDVA), best corrected distant visual acuity (BCDVA), slit-lamp examination, intraocular pressure, and fundus examination. Corneal topography and corneal aberrometry will be performed on all patients using Sirius's Scheimpflug-Placido topography (CSO, Florence, Italy). The CSO topography system analyzes a total of 6144 corneal points of a corneal area within a circular annulus outlined by an inner radius of 0.33 mm and an outer

Timeline

Start date
2025-03-01
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-03-05
Last updated
2025-03-05

Source: ClinicalTrials.gov record NCT06860061. Inclusion in this directory is not an endorsement.